Skip to main content

Crewe Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1730033 SALT LAKE CITY, UT

Position in REGN

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$6,235
+$54 QoQ
Shares Held
10
+25.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,249
of 1,322 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Crewe Advisors LLC holds $953,982 across 16 Biotechnology names. REGN ranks #14 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,235 10
2026-03-31 $6,181 8
2025-12-31 $6,174 8
2025-09-30 $4,498 8
2025-03-31 $634 1
2024-09-30 $30,485 29
2024-06-30 $30,479 29
2024-03-31 $27,912 29
2023-06-30 $718 1
2023-03-31 $5,751 7
2022-12-31 $9,379 13
2022-09-30 $35,132 51
2022-06-30 $20,689 35
2021-09-30 $7,262 12
2021-06-30 $6,702 12
2021-03-31 $5,677 12
2020-12-31 $5,797 12
2020-09-30 $12,874 23